ID

43906

Description

A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011); ODM derived from: https://clinicaltrials.gov/show/NCT00397683

Lien

https://clinicaltrials.gov/show/NCT00397683

Mots-clés

Versions (2)
  1. 26/05/2017 26/05/2017 -
  2. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Osteoarthritis NCT00397683

Anglais

Eligibility Osteoarthritis NCT00397683

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with symptomatic knee osteoarthritis for at least 6 months based on clinical and radiographic criteria
Description

Knee Osteoarthritis Symptomatic Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0409959
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0449238
patients should be in general good health and must have a certain level of knee pain or be taking pain medicines on most days
Description

General health good | Knee pain Level | Analgesics Frequency

Type de données

boolean

Alias
UMLS CUI [1]
C1277245
UMLS CUI [2,1]
C0231749
UMLS CUI [2,2]
C0441889
UMLS CUI [3,1]
C0002771
UMLS CUI [3,2]
C0376249
specific radiographic (x-ray) and mri features must also be satisfied
Description

Feature Radiography Specific | Feature Magnetic Resonance Imaging Specific

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348519
UMLS CUI [1,2]
C0034571
UMLS CUI [1,3]
C0205369
UMLS CUI [2,1]
C2348519
UMLS CUI [2,2]
C0024485
UMLS CUI [2,3]
C0205369
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
non-osteoarthritic causes of knee pain
Description

Knee pain Causes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0231749
UMLS CUI [1,2]
C0015127
ineligibility to undergo mri of the knee due to patient tolerability or safety reasons
Description

Ineligibility MRI Knee | Ineligibility Due to Patient safety

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0024485
UMLS CUI [1,3]
C0022742
UMLS CUI [2,1]
C1512714
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C1113679
previous septic arthritis, tibial osteotomy or knee replacement in both knees
Description

Arthritis, Infectious | Osteotomy of tibia | Knee Replacement Both knees

Type de données

boolean

Alias
UMLS CUI [1]
C0003869
UMLS CUI [2]
C0187826
UMLS CUI [3,1]
C0086511
UMLS CUI [3,2]
C0230434
acute injury of knee ligaments or meniscus in past 2 years
Description

Injury of ligament of knee | Meniscus injury

Type de données

boolean

Alias
UMLS CUI [1]
C0877583
UMLS CUI [2]
C1096124
knee arthroscopy in past 12 months
Description

Arthroscopy of knee

Type de données

boolean

Alias
UMLS CUI [1]
C1304878
anticipated arthroscopy or surgery in next 18 months
Description

Arthroscopy Anticipated | Operative Surgical Procedures Anticipated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003904
UMLS CUI [1,2]
C3840775
UMLS CUI [2,1]
C0543467
UMLS CUI [2,2]
C3840775
use of intra-articular injections of hyaluronan (e.g. hyalgan (tm), synvisc (tm), orthovisc (tm)) in past 6 months, or injections of glucocorticoids (e.g. kenalog (tm), aristospan (tm), depo-medrol (tm)) in past 3 months or anticipated knee injections during the study
Description

Hyaluronan Intra-Articular Injection | Hyalgan Intra-Articular Injection | Synvisc Intra-Articular Injection | Orthovisc Intra-Articular Injection | Glucocorticoids Injection | Kenalog Injection | Aristospan Injection | Depo-Medrol Injection | Knee injection Anticipated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020196
UMLS CUI [1,2]
C0021488
UMLS CUI [2,1]
C0598621
UMLS CUI [2,2]
C0021488
UMLS CUI [3,1]
C0723570
UMLS CUI [3,2]
C0021488
UMLS CUI [4,1]
C1311677
UMLS CUI [4,2]
C0021488
UMLS CUI [5,1]
C0017710
UMLS CUI [5,2]
C1828121
UMLS CUI [6,1]
C0699689
UMLS CUI [6,2]
C1828121
UMLS CUI [7]
C0718654
UMLS CUI [8,1]
C0057476
UMLS CUI [8,2]
C1828121
UMLS CUI [9,1]
C0187946
UMLS CUI [9,2]
C3840775
glucosamine or chondroitin sulfate are allowable if they are at a stable dose for past 3 months and will continue at that dose during the study
Description

Glucosamine Dose Stable | Chondroitin Sulfates Dose Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0017718
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0008466
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
other exclusion criteria apply-please ask the study doctor for details
Description

Exclusion Criteria Additional

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062
Retour au début de la page

Similar models

Eligibility Osteoarthritis NCT00397683

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Knee Osteoarthritis Symptomatic Duration
Item
patients with symptomatic knee osteoarthritis for at least 6 months based on clinical and radiographic criteria
boolean
C0409959 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
General health good | Knee pain Level | Analgesics Frequency
Item
patients should be in general good health and must have a certain level of knee pain or be taking pain medicines on most days
boolean
C1277245 (UMLS CUI [1])
C0231749 (UMLS CUI [2,1])
C0441889 (UMLS CUI [2,2])
C0002771 (UMLS CUI [3,1])
C0376249 (UMLS CUI [3,2])
Feature Radiography Specific | Feature Magnetic Resonance Imaging Specific
Item
specific radiographic (x-ray) and mri features must also be satisfied
boolean
C2348519 (UMLS CUI [1,1])
C0034571 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C2348519 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Knee pain Causes
Item
non-osteoarthritic causes of knee pain
boolean
C0231749 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
Ineligibility MRI Knee | Ineligibility Due to Patient safety
Item
ineligibility to undergo mri of the knee due to patient tolerability or safety reasons
boolean
C1512714 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0022742 (UMLS CUI [1,3])
C1512714 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C1113679 (UMLS CUI [2,3])
Arthritis, Infectious | Osteotomy of tibia | Knee Replacement Both knees
Item
previous septic arthritis, tibial osteotomy or knee replacement in both knees
boolean
C0003869 (UMLS CUI [1])
C0187826 (UMLS CUI [2])
C0086511 (UMLS CUI [3,1])
C0230434 (UMLS CUI [3,2])
Injury of ligament of knee | Meniscus injury
Item
acute injury of knee ligaments or meniscus in past 2 years
boolean
C0877583 (UMLS CUI [1])
C1096124 (UMLS CUI [2])
Arthroscopy of knee
Item
knee arthroscopy in past 12 months
boolean
C1304878 (UMLS CUI [1])
Arthroscopy Anticipated | Operative Surgical Procedures Anticipated
Item
anticipated arthroscopy or surgery in next 18 months
boolean
C0003904 (UMLS CUI [1,1])
C3840775 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
Hyaluronan Intra-Articular Injection | Hyalgan Intra-Articular Injection | Synvisc Intra-Articular Injection | Orthovisc Intra-Articular Injection | Glucocorticoids Injection | Kenalog Injection | Aristospan Injection | Depo-Medrol Injection | Knee injection Anticipated
Item
use of intra-articular injections of hyaluronan (e.g. hyalgan (tm), synvisc (tm), orthovisc (tm)) in past 6 months, or injections of glucocorticoids (e.g. kenalog (tm), aristospan (tm), depo-medrol (tm)) in past 3 months or anticipated knee injections during the study
boolean
C0020196 (UMLS CUI [1,1])
C0021488 (UMLS CUI [1,2])
C0598621 (UMLS CUI [2,1])
C0021488 (UMLS CUI [2,2])
C0723570 (UMLS CUI [3,1])
C0021488 (UMLS CUI [3,2])
C1311677 (UMLS CUI [4,1])
C0021488 (UMLS CUI [4,2])
C0017710 (UMLS CUI [5,1])
C1828121 (UMLS CUI [5,2])
C0699689 (UMLS CUI [6,1])
C1828121 (UMLS CUI [6,2])
C0718654 (UMLS CUI [7])
C0057476 (UMLS CUI [8,1])
C1828121 (UMLS CUI [8,2])
C0187946 (UMLS CUI [9,1])
C3840775 (UMLS CUI [9,2])
Glucosamine Dose Stable | Chondroitin Sulfates Dose Stable
Item
glucosamine or chondroitin sulfate are allowable if they are at a stable dose for past 3 months and will continue at that dose during the study
boolean
C0017718 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0008466 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Exclusion Criteria Additional
Item
other exclusion criteria apply-please ask the study doctor for details
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial